MedPath

Carvedilol Treatment in Patients with Transfusion-Dependent Thalassemia

Not Applicable
Completed
Conditions
Transfusion-dependent thalassemia with ventricular diastolic dysfunction
Circulatory System
Registration Number
ISRCTN14221392
Lead Sponsor
Thailand Research Fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
15
Inclusion Criteria

1. Severe forms of homozygous beta-thalassemia and beta-thalassemia/hemoglobin E disease
2. Transfusion-dependent thalassemia
3. Aged 8-25 years
4. Left ventricular diastolic dysfunction

Exclusion Criteria

N/A

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath